Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
72 participants
INTERVENTIONAL
2019-07-31
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Of Zinc Towards The Outcome on Children With Sepsis
NCT06556511
The Impact of Zinc Supplementation on Innate Immunity and Patient Safety in Sepsis
NCT02130388
The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock
NCT05402553
Adjuvant Use of Neostigmine in Sepsis and Septic Shock.
NCT04130230
Role of Vitamin D Therapy in Recovery From Early Neonatal Sepsis (Randomized Controlled Trial)
NCT05969327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study included 72 cases that were randomly divided into 2 groups
A- Group A (Zinc treated group):
Included 36 cases who received oral zinc sulfate supplementation at doses ranging from 10 mg (infants) to 20 mg (under-five children) of elemental zinc per day, a dosage that is safe in these children.
B- Group B:
Included 36 cases who didn't receive zinc sulfate supplementation.
Method of randomization:
The cases were randomly divided into two groups using the closed envelope technique. The numbers from 1 to 72 were written in flat pieces of papers and put in closed envelopes that were randomly distributed to the participants.
The cases with the odds number were allocated to the zinc treated group while the cases with the even numbers were allocated to the other group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment group
who received oral zinc sulfate supplementation on dose doses ranging from 10 mg (infants) to 20 mg (under-five children) of elemental zinc per day, a dosage that is safe in these children
oral zinc sulfate
Oral zinc sulfate at dose 10 to 20 mg daily for 10 days
Control group
who didn't receive zinc sulfate supplementation.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral zinc sulfate
Oral zinc sulfate at dose 10 to 20 mg daily for 10 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Those who are regularly taking vitamin or mineral supplementations
2 Months
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amal Osman
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angi A Al Wakil, MD
Role: PRINCIPAL_INVESTIGATOR
Mansoura University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University Children's Hospital
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS.19.05.614
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.